Loberanes, Merlinda B.
HRN: 28-64-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2026
CEFTRIAXONE 1G (VIAL)
04/28/2026
05/05/2026
IV
2g
OD
CAP MR
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: